ANS pharmacology and pathophysiology Flashcards

1
Q

how is phenylephrine metabolized

A

MAO

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

2 examples of mixed function alpha and beta agonists

A

labetalol
carvedilol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

cholinergic agonists (3)

A

nicotine
bethanechol
physostigmine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

direct vasodilators/nitrodilators (3)

A

nitroprusside, NTG, hydralazine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

does PAP increase with phenylephrine

A

yes d/t pulmonary vasoconstriction and increase in venous return

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

in the event of a neo OD, what is the drug you give and the drug you AVOID

A

give: a2 antagonist such as phentolamine
avoid: beta antagonists- can cause pedema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

elimination half life of clonidine

A

8 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

elimination half life of dexmedetomidine

A

2 hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

MOA of clonidine

A

inhibits NE release causing vasodilation and diminishing sympathetic outflow, decreasing HR and BP
sedation via locus coeruleus
pain modification and analgesia via dorsal horn of SC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

clinical uses for clonidine (3)

A

treating HTN
controlling opiate and nicotine withdrawal manifestations
dx of pheochromocytoma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

isoproterenol and
airway resistance
metabolism
receptor binding
gtt dose
primary use

A

airway resistance: decreased
metabolism: COMT
receptor binding: B1>B2 (.015-.15mcg/kg/min)
primary use: drug pacing. less commonly used now

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

dobutamine and
airway resistance
metabolism
receptor binding
primary use

A

airway resistance: no change
metabolism: COMT
receptor binding: B1>B2>A1 (2-20mcg/min)
primary use: cardiogenic shock, stress test

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

epinephrine IV infusion dose

A

.01-.2mcg/kg/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

systemic effects of catecholamines include

A
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

NE receptors it effects

A

mostly A1 and B1, minimal B2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

IV infusion dose of NE

A

.1-.22mcg/kg/min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

NE is first line therapy in

A

distributive shock

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

isoproterenol is derived from

A

dopamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

short acting B2 agonist inhalers include (3)

A

albuterol
levalbuterol
terbutaline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

long acting B2 agonist inhalers include (2)

A

salmeterol
formoterol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

which adrenoreceptor agonist is metabolized by the liver

A

ephedrine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

what is the alpha antagonist family of drugs usually used to treat (4)

A

HTN
HF
BPH
pheo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

MOA of phenoxybenzaprine and use/route of admin

A

non selective non competitive alpha antagonist that blocks NE and epi, lowering PVR and BP
HR may increased d/t increase in free, unbound NE

almost exclusively used in pheo’s preop to decrease BP

PO!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

what terminates the clinical effect of phenoxybenzaprine

A

since its irreversible, only the synthesis of new receptors can terminate its effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

best tx for phenoxybenzaprine induced severe hoTN

A

vasopressin and fluids.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

MOA of phentolamine and route of admin (and what reflex it elicits)

A

noncompetitive non selective alpha antagonist
action can be overcome using an alpha agonist though such as neo or NE
potent rapidly acting vasodilator that causes baroreceptor mediated reflex tachycardia and should be used with caution in CAD patients

IV!!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

DOA of phenozybenzaprine versus phentolamine

A

phentolamine has a much shorter half life of <10 minutes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

phentolamine clinical use

A

can be used to tx extravasation from NE or epi

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

phentolamine has an affinity for which random receptor

A

5HT- causes stomach acid secretion and mast cell degranulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

prazosin receptors, MOA, SE

A

highly selective a1 receptor antagonist with an affinity for a1>a2 1000:1
decreases PVR in arterioles and veins, which increases venous capacitance and decreases preload and BP with little change in HR
SE: postural/orthostatic HoTN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

3 analogs of prazosin (a1 selective antagonist) include

A

terazosin
doxazosin
tamsulosin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

terazosin as compared to prazosin

A

less potent, longer acting, mainly used to tx prostate hypertrophy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

doxazosin and tamsulosin as compared to prazosin

A

weaker vascular effects, primarily used in treating prostate hypertrophy. anesthetic induced HoTN can still be exacerbated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

yohimbine receptor affinity, MOA, uses (5)

A

selective a2 adrenergic antagonist
increases PSNS activity and decreases SNS activity
used for ED, athletic performance, weight loss, HTN, diabetic neuropathy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

propanolol receptor affinity, MOA, SE

A

nonselective B1/B2 antagonist that inhibits actions of NE, epi, dopa, dobut, and isoproterenol
possesses membrane stabilizing effects at high doses which means it also acts as an anti arrhythmic
SE: B2 related: bronchoconstriction, hypoglycemia, peripheral vascular constriciton. may aggravate raynaudus

(selective: A-N. non selective: O-Z. alpha: not -olol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

non selective beta adrenergic antagonist examples include (5)

A

carvedilol
pindolol
nadolol
sotalol
timolol

(selective: A-N. non selective: O-Z. alpha: not -olol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

non selective BB with very long half life

A

nadolol

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

non selective BB with simpathomimetic effects

A

pindolol–>weak beta agonist effects, associated with less HR slowing/HoTN

(selective: A-N. non selective: O-Z. alpha: not -olol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

metoprolol receptor selectivity, MOA, uses (4), SE

A

B1
limits HR increase, useful in patients with ischemic disease
used in patients with angina, HF, afib, HTN

(selective: A-N. non selective: O-Z. alpha: not -olol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

esmolol receptor selectivity, uses, onset and DOA,

A

B1 selective
uses: preventing acute increases in HR intraop
onset/DOA: swift onset, DOA <15 min, can titrate to effect
(10-80mg bolus or 50-330mcg/kg/min)

(selective: A-N. non selective: O-Z. alpha: not -olol)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

atenolol receptor selectivity, MOA, uses, onset, DOA

A

receptor selectivity: B1 receptor antagonist, synthetic
uses: prevents increase in HR, decreases electrical conductivity and inotropy from release of NE
increases cardiac work and decreases O2 demand
DOA: 25-200mg BID to reach full effect in 1-2w (IV or PO)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

labetalol receptor selectivity, MOA, uses, onset, DOA, SE

A

adrenergic antagonist with a1 and non selective B adrenergic activity (B>a 7:1)
MOA: a1 antagonism vasodilates and decreases PVR. b1 antagonism can cause mild decrease in HR, B2 antagonism can cause bronchospasm
can decrease HR without causing baroreceptor reflex
uses: primary for acute HTN (make sure HR is ok because bradycardia will be exacerbated)
doa: t1/2 6 hours. metabolized by liver, eliminated by kidney.

(selective: A-N. non selective: O-Z. alpha: not -olol)

43
Q

carvedilol receptor selectivity, MOA, uses (4), other

A

receptor selectivity: a1, non selective B1/B2
MOA: vasodilation with modest HR reduction
uses: HF, LV dysfx, HTN, acute MI
has anti oxidant and anti inflammatory properties

44
Q

methacholine MOA/use

A

m3 receptor agonist that evokes bronchospasm, increases airway secretions, impairs peak expiratory flow rates
administered to ID if patient has reactive aw disease when they dont have any clinical outward signs of asthma

45
Q

bethanachol MOA/use

A

selective m3 agonist for GI/urinary tract and is used postop to tx urinary retention

46
Q

2 cholinergic agonists that produce miosis and can maybe help with glaucoma

A

carbamycholine
pylocarpine

47
Q

which commonly used anticholinergic is a quaternary amine

A

glyco (aka does not cross BBB)

48
Q

muscarinic (anticholinergic) toxicity tx

A

physostigmine 1-2mg IV

49
Q

effects of CCB’s on myocardium

A

decrease in after load, preload, contractility.
increase in diastolic perfusion, decrease in exercise vasoconstriction or spasm

50
Q

heart and VSMC’s have two types of calcium channels. what are they and what do our CCB’s target

A

transient (T) form and long (L) form
our CCB’s target the L form

51
Q

what are CCB’s used to treat (5)

A

HTN, arrhtyhmias, PVD, cerebral vasospasm, angina

52
Q

3 classes of CCB’s and examples

A
  1. dihydropirodines: nifedipine, nimodipine, nicardipine, clevidipine
  2. benzothiazepines: diltiazem
  3. phenylalkamines: verapamil
53
Q

two best CCB’s for HR control and why

A

verapamil and diltiazem (class 4 anti arrhythmic that suppress SA node discharge/AV node conduction)

54
Q

order of CCB’s to use for control of contractility (4)

A

verapamil>nifedipine>diltiazem>nicardipine

55
Q

CCB used for cerebral vasospasms

A

nimodipine

56
Q

two best CCB’s to decrease SVR

A

nicardipine (good coronary anti spasmodic) and nimpodipine

57
Q

do CCB’s produce greater relaxation of arterial or venous smooth muscles?

A

aterial

58
Q

best CCB for supra ventricular arrhythmias

A

verapamil (or dilt)

59
Q

does carvedilol have any negative chronotropic or inotropic effects?

A

nope

60
Q

half life of clevidipine and reflex that may occur

A

~2 minutes, baroreceptor mediated increase in HR

61
Q

NTG primary site of dilation, MOA, uses, cautions

A

dilates venules primarily at low doses. as dose increases, dilates arterioles and increase in HR is seen
MOA: NO. arterial CO and BP decrease r/t decreased preload. improves O2 supply/demand
uses: first line for cardiac ischemia d/t dilation of both normal AND stenotic arteries
cautions: when using a NO liberation drug like sildenafil d/t severe HoTN

62
Q

sodium nitroprusside (SNP) site of dilation, dose caution, byproduct

A

ultra short acting NO donor with potent venous and arteriolar dilation activity which decreases after load AND preload
do not exceed 500mcg/kg and dont give any faster than 2 min
coronary steal, reflex tachycardia (B1 antagonist can help)
cyanide is produced after SNP admin which can inhibit aerobic metabolism. also binds with HGB forming metHGB and binding to sulfur to form thiocyanate

63
Q

hydralazine site of action (4), MOA, SE

A

result of activation of Ktp channels resulting in increased Ca2+
causes dilation in cardiac, cerebral, splanchnic, and renal vasculature leading to reduced SVR and BP. preserves LV preload and does not dilate venous capacitance vessels
tachycardia (B1 antagonist can help) r/t baroreceptor reflex activity

64
Q

minoxidil SE’s that are weird and what its now used for

A

has bad reflex tachycardia so have to give B1 antagonist with it
hypertrichosis (hair growth), salt and water retention.
now used to tx scalp hair loss

65
Q

examples of PDE5 inhibitors (3)

A

sildenafil
tadalafil
vardenafil

66
Q

MOA of PDE5 inhibitors

A

increase level of cGMP and target lungs and penis
no cGMP breakdown means increase in NO vasodilation. which relaxes smooth muscles and increases BF
promote pulmonary vasodilation and decrease p.artery pressure

67
Q

examples of PDE4 inhibitors

A

roflumilast
apremilast
ibudilast

68
Q

MOA of PDE4 inhibitors

A

increase cAMP, targeting airway skin and immune system
can cause smooth muscle relaxation in those with hyper reactive airways
useful in skin, bowel, joint inflammation

69
Q

examples of PDE3 inhibitors

A

milrinone and cilostazol

70
Q

MOA of PDE3 ihibitors

A

increase cAMP and cGMP and are useful in CV disease
increased inotropy with VSMC relaxation= indicators
promote relaxation in peripheral vessels to help with intermittent claudication
prevent platelet aggregation for thrombosis and prophylaxis

71
Q

theophylline

A

increases cAMP in airways and is useful in patients with asthma and COPD

72
Q

V1 receptors mediate

A

CV effects such as SVR

73
Q

V2 receptors mediate

A

function in kidneys and ADH

74
Q

V3 receptors are found in

A

pituitary gland and regulate autocoids (biological factors that act as local hormones)

75
Q

vasopressins major endogenous roles include (3)

A

water, osmolar, and BP homeostasis

76
Q

overview of RAAS loop

A
  1. renin acts on angiotensinogen (produced by liver) circulating in blood to produce angiotensin 1
  2. ACE (found in lung) removed 2 amino acid residues from angiotensin 1 to produce angiotensin 2
  3. angiotensin 2 acts on renal tubules to increase Na/H2O reabsorption and stimulate K excretion
77
Q

role of angiotensin 2 on angiotensin receptor types 1 and 2

A

AT1: potent vasoconstrictor of kidney and mesenteric arterioles
AT2: regulates vascular response, cardiac growth response, and fibrotic response in other tissues

78
Q

what triggers release of epi and NE from adrenal medulla

A

AT2

79
Q

what is stimulated by AT2 to amplify Na reabsorption and K excretion

A

aldosterone

80
Q

ACEI clinical uses (4)

A

HTN, CHF, mitral regurg, LV dysfx

81
Q

ACEI effects include

A

decrease generation of angiotensin
reduce LV after load, reducing arterial vasomotor tone
cause plasma aldosterone levels to fall
decrease water and sodium retention
block breakdown of bradykinin (endogenous vasodilator)
decrease concentration of LDL cholesterol
does not impair baroreceptors (so orthostatic HoTN isn’t an issue)
renal protective effects in DM patients

82
Q

SE of acei’s (5)

A

dry cough
hyperkalemia
fatigue
renal dysfunction
angioedema

83
Q

which acei is a pro drug

A

elanapril (elanaprat is pro drug)

84
Q

MOA of ARB’s

A

have affinity for AT1 receptor which inhibits AT2 from exerting its effect (better than ACEI’s do)

85
Q

characteristics of ANS modification from volatile agents include (6)

A

GABA-A receptor agonism (chloride conductance)
altered myocardial Ca2+ function –> myocardial depression
altered Ca2+ function im VSMC–> vasodilation
depression of baroreceptor reflex
antagonism of SA node automaticity (can lead to nodal rhythm)
impairs ventilatory response to CO2 and O2
uncoupling of cerebral BF auto regulation (usually >.5MAC)

86
Q

inhaled agents decrease (4)

A

CO, BP, CI, SVR

87
Q

how to inhaled agents promote anti arrhythmic effects

A

prolong QT interval by inhibiting K reflux to allow for repolarization

88
Q

propofol MOA and SE

A

GABAa receptor agonist
depression of baroreceptor reflex, mild bronchodilation

89
Q

etomidate MOA and SE

A

GABAa receptor agonist
vasoconstrictor reducing CBF and ICP
does not block SNS response to laryngoscopy
minimal changes in HR SV and CO

90
Q

midazolam MOA and SE

A

GABAa receptor agonist
induction dose can decrease BP and SVR, dose dependent decrease in respiratory drive and aw reflex.
when used as sedative, produces anxiolysis without significant CV or respiratory effect

91
Q

MOA of class 1B antiarrhythmics (lidocaine being the standard drug)

A

suppress automaticity by increasing electrical stimulation threshold of ventricle and his purkinje system and inhibiting spontaneous depol during diastole

92
Q

resting HR of transplanted heart

A

100-120 (set by SA node)

93
Q

digitalis effect on recipient heart

A

increase of contractility due to its direct cardiac effects

94
Q

verapamil effect on recipient heart

A

AV node block due to direct effect

95
Q

effect of BB on recipient heart

A

increased antagonist effect

96
Q

which reflex is intact with recipient heart

A

bainbridge since its SA node mediated

97
Q

Paraganglioma overview

A

neuroendocrine tumors that arise from neural crest cells. in adrenal locations (like pheos) but rarely secrete vasoactive substances. when they do, its usually norepinephrine.
can also secrete serotonin or kallikrein which will produce sx including carcinoid like sx like bronchoconstriction, diarrhea, HA, flushing, HoTN
histamine/bradykinin release: bronchoconstriction/HoTN
located usually: lung, head, neck, CA, glossopharyngeal nerve, jugular vein, middle ear.
small tumors can be radiated or embolized
anesthetic concern: cranial nerve paragangliomas can cause swallowing impairment, aspiration, aw obstruction
surgical dissection of one near IJ increases risk of air embolism

98
Q

MSA overview

A

degeneration and dysfx of diverse CNS structures such as basal ganglia, cerebellar cortex, locus coeruleus, pyramidal tracts, vagal motor nuclei
-autonomic dysfx predominating is usually from locus coeruleus, intermediolateral column of SC, and peripheral autonomic neurons and manifests as orthostatic HoTN

99
Q

MSA s/sx

A

urinary retention
bowel dysfunction
impotence
postural HoTN
pupillary reflexes can be sluggish
control of breathing abnormal
baroreceptor reflex failure

100
Q

MSA anesthetic considerations

A

bradycardia r/t HoTN best treated with atropine/glyco
s/sx light anesthesia harder to ID because SNS less reactive
any anti parkinson meds should be continued in preoperative period

101
Q

BB’s with first letter a-n are
BB’s with first letter o-z are

A

cardioselective (B1)
non selective (B1/B2)

102
Q

BB’s with intrinsic sympathomimetic activity or partial agonists mnemonic

A

Buci and Celi took Cart Pin and Pen to Ace Lab
Bucindolol
Celiprolol
Cartelol
Penbutolol
Acebutalol
Labetalol

103
Q

BB’s with membrane stabilizing or na+ blocking action (anti arrhythmic activity/LA activity) mnemonic

A

professor meto took pin to ace lab
propanolol (max MSA)
metoprolol
pindolol
acebutolol
labetalol